Neurobiological alteration in agitation in Alzheimer's disease and possible interventions

被引：1
|
作者：
Rao, Jagadeesh S. [1 ]
Tangarife, Maria Alejandra [1 ]
Mukunda, Ram [1 ]
机构：
[1] India Globalizat Capital IGC Pharm, Sci Dept, Potomac, MD 20859 USA
来源：
FRONTIERS IN PSYCHIATRY | 2024年 / 15卷
关键词：
agitation; Alzheimer's disease; neuroinflammation; GABA; CBR-1; THC; melatonin; SYMPTOMS; DRONABINOL; CORTEX; GABA;
D O I：
10.3389/fpsyt.2024.1412901
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Inflammatory signaling pathways in Alzheimer's disease: Mechanistic insights and possible therapeutic interventions
    Almutary, Abdulmajeed G.
    Begum, M. Yasmin
    Kyada, Ashish Kumar
    Gupta, Saurabh
    Jyothi, S. Renuka
    Chaudhary, Kamlesh
    Sharma, Swati
    Sinha, Aashna
    Abomughaid, Mosleh Mohammad
    Imran, Mohd
    Lakhanpal, Sorabh
    Babalghith, Ahmad O.
    Abu-Seer, Eman Adnan
    Avinash, D.
    Alzahrani, Hassan A.
    Alhindi, Abdulghani A.
    Iqbal, Danish
    Kumar, Sandeep
    Jha, Niraj Kumar
    Alghamdi, Saad
    AGEING RESEARCH REVIEWS, 2025, 104
  • [42] Therapeutic interventions in Alzheimer's disease
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (02) : 118 - 119
  • [43] Memory encoding failure in Alzheimer's disease: Neurobiological evidence
    Ford, JM
    Lee, J
    Keller, J
    Askari, N
    PSYCHOPHYSIOLOGY, 2002, 39 : S35 - S35
  • [44] Visuospatial Memory Alteration in Alzheimer’s Disease
    Sen Lin
    Neuroscience Bulletin, 2020, 36 : 829 - 830
  • [45] Visuospatial Memory Alteration in Alzheimer's Disease
    Lin, Sen
    NEUROSCIENCE BULLETIN, 2020, 36 (08) : 829 - 830
  • [46] The alteration and role of glycoconjugates in Alzheimer's disease
    Kang, Yue
    Zhang, Qian
    Xu, Silu
    Yu, Yue
    FRONTIERS IN AGING NEUROSCIENCE, 2024, 16
  • [47] Visuospatial Memory Alteration in Alzheimer's Disease
    Sen Lin
    Neuroscience Bulletin, 2020, (08) : 829 - 830
  • [48] Sex Differences in Cognitive and Neurobiological Markers of Alzheimer's Disease
    O'Hara, J.
    Norton, D.
    Koscik, R.
    Lambrou, N.
    Wyman, M.
    Adrienne, J.
    Bouges, S.
    Zuelsdorff, M.
    Flowers-Benton, S.
    ECarlsson, Jonaitis C.
    Johnson, S.
    Asthana, S.
    Gleason, C.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2019, 34 (06) : 1041 - 1042
  • [49] Treating agitation and aggression in patients with Alzheimer's disease with escitalopram
    Veranic, Lea Zmuc
    Pregelj, Peter
    Jerin, Ales
    Psychogeriatrics, 2016, 16 (06) : 384 - 385
  • [50] Circadian rhythms of agitation in institutionalized patients with Alzheimer's disease
    Martin, J
    Marler, M
    Shochat, T
    Ancoli-Israel, S
    CHRONOBIOLOGY INTERNATIONAL, 2000, 17 (03) : 405 - 418
12345